Seed, Series A
$500K – $3.0M
30+ companies
6 partners
Investment Thesis
Benelux-based healthcare investor backing biotech, medtech and digital health companies with strong science and clinical validation.
Meet the Team
Marc Lohrmann
President And General Manager
Dr. Christian Schneider
Managing Partner Vesalius Biocapital Fund 1, Fund 2 and Fund 3
Guy Geldhof
CFO Vesalius Biocapital Fund 1, Partner Fund 2 and Managing Partner Fund 3
Stéphane Verdood
Managing Partner Vesalius Biocapital Fund 1, Fund 2 and Fund 3
Dr. David Braga Malta
Venture Partner Vesalius Biocapital Fund 3
Industry Focus
Invests In
Portfolio Companies (30)
Other
Confo Therapeutics
Aphea.Bio
activaero
"Discovered via firm_website (high confidence)"
Developed controlled breathing technologies and inhalation devices for therapeutics.
Amakem
"Discovered via firm_website (high confidence)"
Developed kinase inhibitors for eye diseases using Localized Drug Action platform.
apitope
"Discovered via firm_website (high confidence)"
bienca
"Discovered via firm_website (high confidence)"
Develops enzymatic systems for food protection using bio-mimicry technology.
complix
"Discovered via firm_website (high confidence)"
Develops novel protein therapeutics based on proprietary Alphabody technology.
Exact Imaging
"Discovered via firm_website (high confidence)"
FF Pharmaceuticals
"Discovered via firm_website (high confidence)"
Fovea
"Discovered via firm_website (high confidence)"
Browse More Investors
Frequently Asked Questions
See if Vesalius Biocapital (Vesalius Ventures) is a match for your startup
Upload your pitch deck to see how well you match with Vesalius Biocapital (Vesalius Ventures) and 200+ other VC firms.